US Stock MarketDetailed Quotes

RNAZ Transcode Therapeutics

Watchlist

3.410
-0.350-9.31%

Trading Dec 31 15:11 ET

2.37MMarket Cap-0.12P/E (TTM)

Transcode Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-59.24%2.15M

17.99%5.11M

-32.16%3.26M

5.37%18.5M

-20.37%4.07M

22.90%5.28M

-7.24%4.33M

38.55%4.81M

198.89%17.55M

82.78%5.11M

Selling and administrative expenses

-52.33%938.03K

-5.78%2.03M

-33.37%1.53M

-14.84%7.15M

-73.87%733.96K

3.04%1.97M

3.34%2.16M

43.89%2.3M

147.31%8.4M

65.15%2.81M

-General and administrative expense

-52.33%938.03K

-5.78%2.03M

-33.37%1.53M

-14.84%7.15M

-73.87%733.96K

3.04%1.97M

3.34%2.16M

43.89%2.3M

147.31%8.4M

65.15%2.81M

Research and development costs

-63.28%1.23M

3.90%3.08M

-32.12%1.76M

19.85%12.26M

25.19%3.36M

9.81%3.34M

13.20%2.97M

37.72%2.59M

271.55%10.23M

109.00%2.69M

Other operating expenses

56.44%-11.95K

----

65.93%-27.06K

14.57%-923.04K

92.90%-27.25K

95.81%-27.44K

-2,171.63%-788.94K

-1,036.04%-79.41K

-288.18%-1.08M

-102.47%-383.77K

Operating profit

59.24%-2.15M

-17.99%-5.11M

32.16%-3.26M

-5.37%-18.5M

20.37%-4.07M

-22.90%-5.28M

7.24%-4.33M

-38.55%-4.81M

-198.89%-17.55M

-82.78%-5.11M

Net non-operating interest income expense

38.12%-10.61K

43.35%-4.3K

-10.15%-9.54K

-337.23%-50.61K

23.01%-17.21K

-290.55%-17.15K

-670.77%-7.6K

-2,059.05%-8.66K

87.74%-11.58K

-4,482.35%-22.35K

Non-operating interest income

36.64%179

-27.64%178

-96.48%168

-74.11%5.29K

-98.58%137

-98.54%131

-81.52%246

979.19%4.77K

2,973.80%20.41K

1,789.41%9.64K

Non-operating interest expense

-37.55%10.79K

-42.85%4.48K

-27.72%9.71K

74.76%55.9K

--17.35K

--17.28K

--7.84K

--13.43K

-66.36%31.99K

----

Other net income (expense)

-157.32K

-72.59K

-55.35K

Gain on sale of security

---157.32K

---72.59K

---55.35K

----

Income before tax

56.20%-2.32M

-19.56%-5.19M

30.94%-3.33M

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

Income tax

Net income

56.20%-2.32M

-19.56%-5.19M

30.94%-3.33M

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

Net income continuous Operations

56.20%-2.32M

-19.56%-5.19M

30.94%-3.33M

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

Minority interest income

Net income attributable to the parent company

56.20%-2.32M

-19.56%-5.19M

30.94%-3.33M

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

56.20%-2.32M

-19.56%-5.19M

30.94%-3.33M

-5.59%-18.55M

20.38%-4.09M

-23.55%-5.3M

7.06%-4.34M

-38.81%-4.82M

-156.67%-17.56M

-83.41%-5.13M

Basic earnings per share

99.67%-5.28

99.17%-24.42

99.73%-21.45

90.44%-3.42K

97.94%-214.987

81.70%-1.6K

69.10%-2.94K

-13.79%-8.04K

-155.10%-35.77K

-82.29%-10.46K

Diluted earnings per share

99.67%-5.28

99.17%-24.42

99.73%-21.45

90.44%-3.42K

97.94%-214.987

81.70%-1.6K

69.10%-2.94K

-13.79%-8.04K

-155.10%-35.77K

-82.29%-10.46K

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-59.24%2.15M	17.99%5.11M	-32.16%3.26M	5.37%18.5M	-20.37%4.07M	22.90%5.28M	-7.24%4.33M	38.55%4.81M	198.89%17.55M	82.78%5.11M
Selling and administrative expenses	-52.33%938.03K	-5.78%2.03M	-33.37%1.53M	-14.84%7.15M	-73.87%733.96K	3.04%1.97M	3.34%2.16M	43.89%2.3M	147.31%8.4M	65.15%2.81M
-General and administrative expense	-52.33%938.03K	-5.78%2.03M	-33.37%1.53M	-14.84%7.15M	-73.87%733.96K	3.04%1.97M	3.34%2.16M	43.89%2.3M	147.31%8.4M	65.15%2.81M
Research and development costs	-63.28%1.23M	3.90%3.08M	-32.12%1.76M	19.85%12.26M	25.19%3.36M	9.81%3.34M	13.20%2.97M	37.72%2.59M	271.55%10.23M	109.00%2.69M
Other operating expenses	56.44%-11.95K	----	65.93%-27.06K	14.57%-923.04K	92.90%-27.25K	95.81%-27.44K	-2,171.63%-788.94K	-1,036.04%-79.41K	-288.18%-1.08M	-102.47%-383.77K
Operating profit	59.24%-2.15M	-17.99%-5.11M	32.16%-3.26M	-5.37%-18.5M	20.37%-4.07M	-22.90%-5.28M	7.24%-4.33M	-38.55%-4.81M	-198.89%-17.55M	-82.78%-5.11M
Net non-operating interest income expense	38.12%-10.61K	43.35%-4.3K	-10.15%-9.54K	-337.23%-50.61K	23.01%-17.21K	-290.55%-17.15K	-670.77%-7.6K	-2,059.05%-8.66K	87.74%-11.58K	-4,482.35%-22.35K
Non-operating interest income	36.64%179	-27.64%178	-96.48%168	-74.11%5.29K	-98.58%137	-98.54%131	-81.52%246	979.19%4.77K	2,973.80%20.41K	1,789.41%9.64K
Non-operating interest expense	-37.55%10.79K	-42.85%4.48K	-27.72%9.71K	74.76%55.9K	--17.35K	--17.28K	--7.84K	--13.43K	-66.36%31.99K	----
Other net income (expense)	-157.32K	-72.59K	-55.35K
Gain on sale of security	---157.32K	---72.59K	---55.35K	----	----	----	----	----	----	----
Income before tax	56.20%-2.32M	-19.56%-5.19M	30.94%-3.33M	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M
Income tax
Net income	56.20%-2.32M	-19.56%-5.19M	30.94%-3.33M	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M
Net income continuous Operations	56.20%-2.32M	-19.56%-5.19M	30.94%-3.33M	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M
Minority interest income
Net income attributable to the parent company	56.20%-2.32M	-19.56%-5.19M	30.94%-3.33M	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	56.20%-2.32M	-19.56%-5.19M	30.94%-3.33M	-5.59%-18.55M	20.38%-4.09M	-23.55%-5.3M	7.06%-4.34M	-38.81%-4.82M	-156.67%-17.56M	-83.41%-5.13M
Basic earnings per share	99.67%-5.28	99.17%-24.42	99.73%-21.45	90.44%-3.42K	97.94%-214.987	81.70%-1.6K	69.10%-2.94K	-13.79%-8.04K	-155.10%-35.77K	-82.29%-10.46K
Diluted earnings per share	99.67%-5.28	99.17%-24.42	99.73%-21.45	90.44%-3.42K	97.94%-214.987	81.70%-1.6K	69.10%-2.94K	-13.79%-8.04K	-155.10%-35.77K	-82.29%-10.46K
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Heat List

Overall

No Data